Obesity is associated with impaired secretion of GH. In contrast, insulin-like growth factor (IGF)-I level is not decreased in obesity. As GH-binding protein (GHBP) is believed to be derived from proteolytic cleavage of the extracellular domain of GH receptor and may be regarded as an intrinsic part of the GH ± IGF-I axis, a certain relevance of body composition to circulating GHBP levels may be expected. GH and insulin have been reported as regulators of GHBP levels. We investigated the GHBP levels in obesity with varying glucose tolerance, and the relationship to body fat distribution, insulin secretion, and GH ± IGF-I axis. We also evaluated the sex differences in GHBP levels and their relationship with sex hormones. 
Objectives
Obesity is associated with impaired secretion of GH. In contrast, insulin-like growth factor (IGF)-I level is not decreased in obesity. As GH-binding protein (GHBP) is believed to be derived from proteolytic cleavage of the extracellular domain of GH receptor and may be regarded as an intrinsic part of the GH ± IGF-I axis, a certain relevance of body composition to circulating GHBP levels may be expected. GH and insulin have been reported as regulators of GHBP levels. We investigated the GHBP levels in obesity with varying glucose tolerance, and the relationship to body fat distribution, insulin secretion, and GH ± IGF-I axis. We also evaluated the sex differences in GHBP levels and their relationship with sex hormones. 
Measurements
Anthropometric measurement, bioelectical impedence for measurement of total body fat, and computed tomography for visceral and subcutaneous fat area at umbilicus levels were taken. All subjects underwent a standard oral glucose tolerance test (OGTT) and GH stimulation test by L-dopa.
Results
Obese NIDDM subjects had the highest GHBP levels and the highest VWR. In obese subjects, GHBP levels were the most strongly correlated with VWR among other parameters (r 0.725, P`0.001). FFA-AUC and IGF-levels were also positively correlated with GHBP levels (r 0.572, P`0.005; r 0.453, P`0.005), whereas insulin-AUC was positively correlated with GHBP in only lean subjects (r 0.474, P`0.005). The GH-AUC to L-dopa stimulation test was decreased in obese subjects and negatively correlated with GHBP levels (r 7 0.432, P`0.005). The GHBP levels were higher but not signi®cant in females than in males in the same glucose tolerance category. In lean males, total and free testosterone levels were negatively correlated with GHBP levels (r 7 0.516, P `0.001; r 7 0.653, P`0.001).
Stepwise multiple linear regression analysis showed that VWR and FFA-AUC signi®cantly contributed to the variability of GHBP in obese subjects (r 2 0.58). In lean subjects, VWR, FFA-AUC and insulin-AUC contributed to the variation of GHBP (r 2 0.51).
Conclusion
There was an weak sexual dimorphism in GHBP levels, which could be in part explained by sex hormones. We demonstrated that the GHBP level was the highest in obese NIDDM which had the most relative visceral fat amount (VWR) and that visceral fat amount was mainly determined by GHBP levels in obese subjects with varying glucose tolerance. This ®nding suggests the possibility of whether GHBP may originate from visceral fat tissue as well as in liver, or proteolysis of GH receptor may increase in hepatic and extrahepatic tissue by FFA and some unknown metabolites associated with visceral fat obesity. Although insulin and GH were not the main regulator of GHBP, no decrease in IGF-I level despite GH hyposecretion suggests that increased GHBP levels re¯ect GH hypersensitivity in order to compensate for decreased GH secretion in obesity.
